DH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Definitive Healthcare Corp (DH) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is showing bearish technical indicators, weak financial performance, and lacks positive catalysts. Analysts have lowered price targets, and there are no strong trading signals or recent influential trades to support a buy decision.
The stock is in a bearish trend with moving averages showing SMA_200 > SMA_20 > SMA_5. RSI indicates oversold conditions at 16.23, but MACD is positively contracting. Key support is at 1.013, and resistance is at 1.25. The stock closed at 1.03, near its support level, with no clear reversal signals.
NULL identified. No recent news or significant positive events.
Analysts have significantly lowered price targets, reflecting weak growth prospects. Financial performance in Q4 2025 showed declines in revenue (-1.21% YoY), net income (-84.23% YoY), and EPS (-82.35% YoY). Gross margin also slightly declined. No recent insider or hedge fund activity indicates confidence in the stock.
In Q4 2025, revenue dropped to $61.53M (-1.21% YoY), net income fell to -$9.32M (-84.23% YoY), and EPS declined to -0.09 (-82.35% YoY). Gross margin decreased slightly to 61.26%. Overall, the company is experiencing significant financial challenges.
Analysts have lowered price targets across the board. Baird reduced the target to $1.90, Stephens to $2, Stifel to $3, Deutsche Bank to $3, and Canaccord to $3. Ratings range from Neutral to Hold, with one Buy rating from Stifel. Analysts highlight uncertainty in growth recovery.
